Pharmacological properties of cardiotoxin isolated from Formosan cobra venom.
D000818:Animals; D001001:Anura; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002462:Cell Membrane / Q000187:drug effects; D002645:Chickens; D002852:Chromatography, Ion Exchange; D003231:Conjunctivitis / Q000139:chemically induced; D004423:Ear / Q000098:blood supply; D004562:Electrocardiography; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006323:Heart Arrest / Q000139:chemically induced; D006325:Heart Atria / Q000187:drug effects; D007082:Ileum; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D009130:Muscle, Smooth / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D010243:Paralysis / Q000139:chemically induced; D051381:Rats; D012039:Regional Blood Flow / Q000187:drug effects; D012911:Snakes; D014118:Toxins, Biological / Q000494:pharmacology* / Q000633:toxicity; D014688:Venoms / Q000032:analysis
D014118:Toxins, Biological; D014688:Venoms